As UK faces surging fuel demand and a potential obesity drug revolution, the nation's economic priorities are tested.
Novo Nordisk eyes Denmark, UK, and Germany for Wegovy pill launch, targeting global weight loss market beyond US dominance.
Novo Nordisk raises 2026 outlook as Wegovy captures 65% of new US prescriptions, while Pandora faces tariff and silver price pressures.
HSBC earnings among top investor events this week alongside Shell, Maersk, and Novo Nordisk.
Shell and other European giants report earnings this week as Gulf fatigue shifts focus to corporate results.